Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitus
Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitus
复制标题
DOI:
10.1136/jnnp.2005.069583
复制
发表时间:
2006-03-01
影响因子:
11
通讯作者:
Scheltens, P
中科院分区:
文献类型:
--
作者:
Biessels, GJ;De Leeuw, FE;Scheltens, P
Background: The risk of Alzheimer's disease ( AD) is increased in type 2 diabetes (DM2). This increased risk has been attributed to vascular comorbidity, but other mechanisms, such as accelerated ageing of the brain, have also been implicated.Objective: To determine whether AD in patients with DM2 is associated with an increased occurrence of vascular lesions in the brain, by increased cerebral atrophy, or a combination of both.Methods: In total, 29 patients with AD and DM2 and 58 patients with AD and without DM2 were included in the study. Clinical characteristics were recorded, and a neuropsychological examination and magnetic resonance imaging (MRI) scan were performed. MRI scans were rated for cortical and subcortical atrophy, medial temporal lobe atrophy, white matter lesions, and infarcts.Results: The neuropsychological profiles of the two groups were identical. Patients with AD and DM2 had increased cortical atrophy on MRI (p < 0.05) compared with the non-DM2 group. In addition, infarcts were more common ( odds ratio 2.4; 95% CI 0.8 to 7.8), but this effect did not account for the increased atrophy. The other MR measures did not differ between the groups.Conclusion: The results suggest that non-vascular mechanisms, leading to increased cortical atrophy, are also involved in the increased risk of AD in DM2.